Treatment of pediatric-onset lupus nephritis : a proposal of optimal therapy
Available in National Diet Library
Find on the publisher's website
NDL Digital Collections
Digital data available
Check on the publisher's website
DOI[10.1007/s10157-017-1381-1]to the data of the same series
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- Hiroshi TanakaKensuke JohTadaatsu Imaizumi
- Publication, Distribution, etc.
- Publication Date
- 2017-03-03
- Publication Date (W3CDTF)
- 2017-03-03
- Periodical title
- Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology
- No. or year of volume/issue
- 21(5)
- Volume
- 21(5)
- ISSN (Periodical Title)
- 1437-7799
- ISSN-L (Periodical Title)
- 1437-7799
- Text Language Code
- eng
- DOI
- 10.1007/s10157-017-1381-1
- Persistent ID (NDL)
- info:ndljp/pid/11636024
- Collection
- Collection (Materials For Handicapped People:1)
- Collection (particular)
- 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- Acquisition Basis
- オンライン資料収集制度
- Date Accepted (W3CDTF)
- 2021-02-10T20:40:42+09:00
- Date Captured (W3CDTF)
- 2021-01-27
- Format (IMT)
- application/pdf
- Access Restrictions
- 国立国会図書館内限定公開
- Service for the Digitized Contents Transmission Service
- 図書館・個人送信対象外
- Availability of remote photoduplication service
- 可
- Periodical Title (URI)
- Periodical Title (Persistent ID (NDL))
- info:ndljp/pid/11636022
- Data Provider (Database)
- 国立国会図書館 : 国立国会図書館デジタルコレクション
- Summary, etc.
- コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- DOI
- 10.1007/s10157-017-1381-1
- Related Material (URI)
- Is Referenced By
- Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cellsLong‐term outcome of tacrolimus‐based immunosuppressive treatment for patients with paediatric‐onset lupus nephritis
- References
- Mizoribine in the treatment of pediatric-onset glomerular diseaseGlomerular expression of myxovirus resistance protein 1 in human mesangial cells: Possible activation of innate immunity in the pathogenesis of lupus nephritisMizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritisClinical features of Japanese children and adolescents with systemic lupus erythematosus: Results of 1980–1994 surveyPractice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest pediatric nephrology consortium and the childhood arthritis and rheumatology research allianceEfficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritisIncidence and prognosis of systemic lupus erythematosus in a 35 year period in <scp>F</scp>ukushima, <scp>J</scp>apanInflammatory Chemokine Expression via Toll-Like Receptor 3 Signaling in Normal Human Mesangial CellsMizoribine selectively attenuates monocyte chemoattractant protein‐1 production in cultured human glomerular mesangial cell: A possible benefit of its use in the treatment of lupus nephritisNovel Anticytomegalovirus Activity of Immunosuppressant Mizoribine and Its Synergism with GanciclovirLong-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical PracticeMesangial Viral and Psuedoviral Immunity: Possible Involvement in the Pathogenesis of Pediatric-Onset Active Lupus NephritisPro: The use of calcineurin inhibitors in the treatment of lupus nephritisPediatric lupus nephritis: more options, more chances?Chloroquine attenuates TLR3/IFN-β signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritisInterferon-Stimulated Gene 15, a Type I Interferon-Dependent Transcript, Is Involved in a Negative Feedback Loop in Innate Immune Reactions in Human Mesangial CellsRituximab therapy for juvenile-onset systemic lupus erythematosusThe pathogenesis, diagnosis and treatment of lupus nephritisOverview of lupus nephritis management guidelines and perspective from AsiaLong-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritisInduction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in childrenIntravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritisEfficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritisSingle dose of rituximab for pediatric-onset refractory systemic lupus erythematosusMechanism of Endosomal TLR Inhibition by Antimalarial Drugs and ImidazoquinolinesLupus nephritis is more severe in children and adolescents than in older adultsMizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study GroupSystemic Lupus Erythematosus – A Disease with A Dysregulated Type I Interferon SystemPattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseaseMethylprednisolone pulse therapy in Japanese children with severe lupus nephritisUpdate on Rituximab: An Established Treatment for All Immune-Mediated Kidney Diseases?Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritisThe outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus – a 20-year experience in AsiaPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusTreatment of young patients with lupus nephritis using calcineurin inhibitorsPseudoviral immunity – a novel concept for lupusProlonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamideProtective Effects of Mizoribine on Cyclosporine A Nephropathy in RatsMizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patientsTherapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritisInitial presentation of childhood-onset systemic lupus erythematosus: A French multicenter studyChildhood onset systemic lupus erythematosus: how is it different from adult <scp>SLE</scp>?Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the “CAPS Registry”Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisIntermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosusSuccessful Treatment of Class V+IV Lupus Nephritis with Multitarget TherapyTreatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune diseaseToll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells
- Data Provider (Database)
- 国立情報学研究所 : CiNii Research
- Original Data Provider (Database)
- 雑誌記事索引データベースCrossref科学研究費助成事業データベース科学研究費助成事業データベースCrossrefCrossref
- Bibliographic ID (NDL)
- 11636024